Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.

To determine the level of antimalarial drug resistance in southern Papua, Indonesia, we assessed the therapeutic efficacy of chloroquine plus sulfadoxine-pyrimethamine (CQ+SP) for Plasmodium falciparum infections as well as CQ monotherapy for P. vivax infections. Patients with P. falciparum failing...

Full description

Bibliographic Details
Main Authors:	Ratcliff, A, Siswantoro, H, Kenangalem, E, Wuwung, M, Brockman, A, Edstein, MD, Laihad, F, Ebsworth, E, Anstey, N, Tjitra, E, Price, R
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
by: Ratcliff, A, et al.
Published: (2007)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
by: Price, R, et al.
Published: (2005)

In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.
by: Siswantoro, H, et al.
Published: (2011)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
by: Hasugian, A, et al.
Published: (2007)

Effects of chloroquine and sulfadoxine/pyrimethamine on gametocytes in patients with uncomplicated Plasmodium falciparum malaria in Colombia
by: Lyda Osorio, et al.
Published: (2002-12-01)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
by: Karyana, M, et al.
Published: (2008)

Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar.
by: Smithuis, F, et al.
Published: (1997)

Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia
by: Warsame M., et al.
Published: (2002-01-01)

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.
by: Lederman, E, et al.
Published: (2006)

Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia.
by: Maguire, J, et al.
Published: (2002)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
by: Sokhina C.S, et al.
Published: (2001-09-01)

Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment
by: TO Ogungbamigbe, et al.
Published: (2008-02-01)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
by: Hasugian, A, et al.
Published: (2009)

Efficacy of existing antimalarial drugs for uncomplicated malaria in Timika, Papua, Indonesia
by: Siswantaro, H, et al.
Published: (2006)

Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
by: Peto, T, et al.
Published: (1985)

A randomized comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Laos.
by: Mayxay, M, et al.
Published: (2003)

Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
by: Smithuis, F, et al.
Published: (2004)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
by: Karyana, M, et al.
Published: (2007)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2007)

Amodiaquine plus artesunate versus dihydroartemisinin-piperaquine for drug resistant P.falciparum and P.vivax in Papua, Indonesia
by: Armedy, R, et al.
Published: (2006)

Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
by: Mayxay, M, et al.
Published: (2003)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
by: Price, R, et al.
Published: (2010)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
by: Basco Leonardo K., et al.
Published: (2002-01-01)

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2011)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
by: Tjitra, E, et al.
Published: (2008)

Sulfadoxine-pyrimethamine for the treatment of malaria.
by: White, N
Published: (1991)

Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros
by: Randrianarivelojosia M., et al.
Published: (2004-12-01)

Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
by: Aleisha R. Brock, et al.
Published: (2017-05-01)

Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018
by: Angela Patricia Guerra, et al.
Published: (2022-10-01)

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
by: Ravenhall, M, et al.
Published: (2016)

Chloroquine sensitive Plasmodium falciparum and P. vivax in central Java, Indonesia.
by: Baird, J, et al.
Published: (1996)

Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
by: Hastings, MD, et al.
Published: (2004)

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
by: Imwong, M, et al.
Published: (2001)

Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia.
by: Sutanto, I, et al.
Published: (2010)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
by: Poespoprodjo, JR, et al.
Published: (2008)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
by: Yeo, T, et al.
Published: (2010)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
by: Suwanarusk, R, et al.
Published: (2007)

Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia
by: Sutanto, I, et al.
Published: (2010)